BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Avipendekin pegol readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Avipendekin pegol\, from ClinicalTrials.g
 ov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05632809-3260@assetmemo.bio
DTSTAMP:20261121T005703Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Avipendekin pegol: Phase 2 readout est. (NCT05632809)
DESCRIPTION:Avipendekin pegol\, phase 2.\nStudy: REStoring lymphoCytes Usin
 g NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)\nEstimated pr
 imary completion: 31 December 2027. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/avipendekin-pegol#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT05632809
URL:https://assetmemo.bio/drug/avipendekin-pegol#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
